European Meeting on HIV & Hepatitis 2020

Feasibility And Efficacy Assessment Of Hepatitis B Vaccination Among Adult Plwh And Vulnerable Population In Vinnytsia Region, Ukraine

Poster

HIV

Viral Hepatitis and Liver Disease

Hepatotoxicity And The Hepatic Panel Analysis Among HIV-Positive Ukrainian Patients Receiving Efaverentz And Dolutegravir-Containing Modes

Poster

HIV

Viral Hepatitis and Liver Disease

Natural Course Of Hepatitis C Virus Infection: Which Factors Affect Spontaneous Clearance Of HCV Among The Ukrainian Population?

Poster

HIV

Viral Hepatitis and Liver Disease

Effectiveness And Tolerability Of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/Taf) In HIV-1-Infected Adult Patients In German Routine Clinical Practice – 12-Month Results Of The BICSTaR Cohort

Poster

HIV

Viral Hepatitis and Liver Disease

Long-Acting Cabotegravir + Rilpivirine For HIV Treatment: Flair Week 96 Results

Poster

HIV

Viral Hepatitis and Liver Disease

Dual Therapy Including Dolutegravir Plus Boosted-Darunavir Ensures High Rate Of Virological Control And Rare Resistance Selection At Failure In Heavily Treatment Experienced PLWH

Poster

HIV

Viral Hepatitis and Liver Disease

Real-World Effectiveness Of Elbasvir/Grazoprevir In The Treatment Of Patients With Hepatitis C Virus Genotype 1A Infection In Norway

Poster

HIV

Viral Hepatitis and Liver Disease

Dual Therapy With Dolutegravir Plus Lamivudine In Virologically Suppressed Patients

Poster

HIV

Viral Hepatitis and Liver Disease

HIV A1 Or B Do Not Differentially Impact Cabotegravir In Vitro Potency Or Durability

Poster

HIV

Viral Hepatitis and Liver Disease

Molecular Epidemiology Of The HIV-1 Infection In Cyprus (2017-2019): A Polyphyletic Infection With An Increasing Prevalence Of Drug Resistance

Poster

HIV

Viral Hepatitis and Liver Disease

HIV Evolution In Patients Initiating Antiretroviral Therapy During Primary Infection

Poster

HIV

Viral Hepatitis and Liver Disease

A Changing Of HIV-1 Genetic Diversity In Russia During The Last Two Decades: Increase Of The Recombinants Prevalence

Poster

HIV

Viral Hepatitis and Liver Disease

Unexpected Rising In The Circulation Of Complex HBV Variants Enriched Of HBsAg Vaccine-Escape Mutations In HBV Genotype-D: Potential Impact On HBsAg Detection/Quantification And Vaccination Strategies

Poster

HIV

Viral Hepatitis and Liver Disease

Residual Phenotypic Susceptibility To Second Generation Nnrti In Multidrug Resistant HIV-1 From The Prestigio Registry

Poster

HIV

Viral Hepatitis and Liver Disease

Susceptibility To HIV-1 Integrase Inhibitors In HIV-1 Sub-Subtype A6 Isolates

Poster

HIV

Viral Hepatitis and Liver Disease

Two-Drug Regimen (2DR) For Initial HIV Treatment? – Lessons Learned From 20 Years Resina Cohort

Poster

HIV

Viral Hepatitis and Liver Disease

Transmitted Drug Resistance To Integrase Based First-Line HIV Antiretroviral Treatment In The MeditRes HIV Collaboration

Poster

HIV

Viral Hepatitis and Liver Disease

Dynamics Of HIV-1 Transmission Clusters In North And Central Italy Over The Years 2012-2019

Poster

HIV

Viral Hepatitis and Liver Disease

Exploring Molecular Characteristics And Evolutionary Dynamics Of The HIV-1 Epidemic In Montenegro Through Phylogenetic Analyses

Poster

HIV

Viral Hepatitis and Liver Disease

Prevalence And Spatiotemporal Dynamics Of The HIV-1 Circulating Recombinant Form 03_AB (CRF03_AB) In The Former Soviet Union

Poster

HIV

Viral Hepatitis and Liver Disease

Short- And Long-Term Direct Medical Costs Of Late And Very Late HIV Presentation

Poster

HIV

Viral Hepatitis and Liver Disease

Cabotegravir + Rilpivirine Every 2 Months Is Noninferior To Monthly: ATLAS-2M Study

Poster

HIV

Viral Hepatitis and Liver Disease

Treatment Outcome Among People Living With Hiv Starting First-Line Rapid Or GRT Guided ART From 2015 To 2018

Poster

HIV

Viral Hepatitis and Liver Disease

Evaluation Of HIV-1 Tropism In Multidrug-Resistant cART Failing Patients

Poster

HIV

Viral Hepatitis and Liver Disease

Assessment Of Genotypic Patterns Associated With HIV-1 Sensitivity To Ibalizumab

Poster

HIV

Viral Hepatitis and Liver Disease

DTG+3TC vs DTG+TDF/FTC (GEMINI1&2): Confirmed Virologic Withdrawals Through Week 96

Poster

HIV

Viral Hepatitis and Liver Disease

Role Of Analitical Treatment Interruption On HIV Peripheral Reservoir Diversification

Poster

HIV

Viral Hepatitis and Liver Disease

In Vitro Activity Of Islatravir Against HIV-1 Mutants Harboring Multiple NRTI Resistance Mutations

Poster

HIV

Viral Hepatitis and Liver Disease

Case Report: Poor Adherence To Dolutegravir Is Associated With Selection Of Resistance Mutations T66I, G118R, E138A And L74I

Poster

HIV

Viral Hepatitis and Liver Disease

Multicentric Castleman Disease HHV-8 Related In A HIV Patient

Poster

HIV

Viral Hepatitis and Liver Disease

HIV Seronegativity After Rapid Art: A Case Demonstrating Future Challenges In HIV Confirmation Testing In The Era Of iART

Poster

HIV

Viral Hepatitis and Liver Disease

Variability In HIV Proviral DNA Genotyping Results From A Single Blood Draw

Poster

HIV

Viral Hepatitis and Liver Disease

Virological Efficacy And Resistance Evaluation In People Living With HIV Starting An STR Regimen

Poster

HIV

Viral Hepatitis and Liver Disease

Resistant Minority Variants Observed In Failing Patients At Week 48 In Anrs 170 Quatuor Trial (A 4/7 Days Maintenance Strategy Vs A 7/7 Days Regimen In Patients With Controlled Viral Load)

Poster

HIV

Viral Hepatitis and Liver Disease

Molecular Characterization In Hcv Late Relapser Patients Treated With Direct-Acting Antiviral (DAA) Drugs

Poster

HIV

Viral Hepatitis and Liver Disease

Clinical And Virological Characteristics And Retreatment Of Patients With Chronic Hepatitis C Virus Infection And Failure To Sofosbuvir, Velapatasvir, And Voxilaprevir In Real-World

Poster

HIV

Viral Hepatitis and Liver Disease

Pharmaco-Virological Algorithm To Target Risk Of Resistance Among A Population Of HIV-Infected Female Sex Workers In Togo

Poster

HIV

Viral Hepatitis and Liver Disease

Impact Of Sexually Transmitted Infections On Seminal HIV Levels Among Undetectable Patients

Poster

HIV

Viral Hepatitis and Liver Disease

The Burden Of Serious Non-AIDS-Defining Events Among Admitted cART-Naive HIV/AIDS Patients In China: An Observational Cohort Study

Poster

HIV

Viral Hepatitis and Liver Disease

Bone Mineral Density In Patients With HIV Infection And Chronic Hepatitis C

Poster

HIV

Viral Hepatitis and Liver Disease

The Prevalence Of Hepatitis B Virus Seromarkers In Patients With HIV/Hcv Coinfection. An Egyptian Cross-Sectional Study

Poster

HIV

Viral Hepatitis and Liver Disease

Seroprevalence And Co-Infections HIV, HBV And HCV Among Clinic Attenders At Laquintinie Hospital In Douala, Cameroon

Poster

HIV

Viral Hepatitis and Liver Disease

Using Next-Generation Sequencing To Understand The Phylogenetics And Networks Of Generalised HIV Epidemics In Africa

Poster

HIV

Viral Hepatitis and Liver Disease

The Efficacy Of First-Line Therapy Based On Rpv In HIV-Infected Patients With Pre-Existing E138A Mutation In Reverse Transcriptase

Poster

HIV

Viral Hepatitis and Liver Disease

Number, Type And Cost Of Microbiological Assays During HIV Pre-Exposure Prophylaxis: The Experience Of A French Hospital

Poster

HIV

Viral Hepatitis and Liver Disease

Breaking Bad: Chems, Sex And Sexual Health

Poster

HIV

Viral Hepatitis and Liver Disease

Determination Of Drug Resistance Of Hepatitis C Virus To NS5A Protein Inhibitors As A New Approach To Personalized Medicine

Poster

HIV

Viral Hepatitis and Liver Disease

Using Next-Generation Sequencing To Assess The Differences In HIV Drug Resistance Pre- And Post-Treatment In A Treatment As Prevention Trial

Poster

HIV

Viral Hepatitis and Liver Disease

Association Of Viral Reservoir With HIV Infection Duration, Viral Load And CD4 Count

Poster

HIV

Viral Hepatitis and Liver Disease

Creation Of An Italian HIV Dna Network For The Validation And Clinical Use Of HIV-1 DNA Quantification Assays

Poster

HIV

Viral Hepatitis and Liver Disease

Exploratory Evaluation For The Optimization Of Next Generation Sequencing HIV-1 Drug Resistance Outcomes Based On An In-House RNA Extraction Protocol

Poster

HIV

Viral Hepatitis and Liver Disease

Associations Between Vitamin D And Fibrosis, Genotype, Viral Load In Patients Having Chronic Hepatitis C

Poster

HIV

Viral Hepatitis and Liver Disease

The Quantification Of HBeAg Levels Differ Among The Different Phases Of Hbv Infection, And Can Predict Therapeutic Outcome In The Setting Of Immunosuppression Driven Hbv Reactivation

Poster

HIV

Viral Hepatitis and Liver Disease

The Effectiveness Of The Application Of Serological Tests And Laboratory Indicators As Part Of Rita For The Detection Of Recent HIV Infection

Poster

HIV

Viral Hepatitis and Liver Disease

Ibalizumab Shows In Vitro Activity Against Group A And Group B HIV-2 Clinical Isolates

Poster

HIV

Viral Hepatitis and Liver Disease

TDF Surveillance And Clinically Relevant Resistance In Spain: 2019 Update

Poster

HIV

Viral Hepatitis and Liver Disease

HCV Resistance Associated Variants Following Directly Acting Agent Therapy Failure- Real Life Data From Poland

Poster

HIV

Viral Hepatitis and Liver Disease

Prevalence Of Transmitted Resistance Mutations To Rilpivirine And Doravirine In Treatment-Naive Patients In A Large Clinical And Resistance Database

Poster

HIV

Viral Hepatitis and Liver Disease

Absence Of GS-6207 Phenotypic Resistance In HIV Gag Cleavage Site Mutants, Patient Isolates With Gag Polymorphisms, And Isolates With Resistance To Existing Drug Classes

Poster

HIV

Viral Hepatitis and Liver Disease

Susceptibility To Bnabs Of Transmitted HIV Variants Among Recent Infections In France

Poster

HIV

Viral Hepatitis and Liver Disease

Genotyping And Treatment Issues With Unusual 1E And 1G HCV Subtypes From African Subjects: Report Of Two Cases

Poster

HIV

Viral Hepatitis and Liver Disease

Substantial Clustered Transmission Of The Acute Hepatitis C Among HIV Co-Infected Men-Who-Have-Sex-With-Men (MSM)

Poster

HIV

Viral Hepatitis and Liver Disease

Antiretroviral Resistance In Patients With Multiple Treatment Failure In A Low-Middle Income Setting

Poster

HIV

Viral Hepatitis and Liver Disease

Prevalence And Correlates Of Pre-Treatment HIV Drug Resistance Among HIV-Infected In The Republic Of Belarus

Poster

HIV

Viral Hepatitis and Liver Disease

Late Presentation And HIV Drug Resistance In Patients Followed In Portugal Between 1984-2017

Poster

HIV

Viral Hepatitis and Liver Disease

Prevalence Of Pretreatment HIV-1 Drug Resistance Among Treatment-Naïve Patients In The Russian Federation, 2014–2018

Poster

HIV

Viral Hepatitis and Liver Disease

Genetic Characteristic Of HIV-1 In Patients With Treatment Failure In Kyrgyzstan In 2017-2018

Poster

HIV

Viral Hepatitis and Liver Disease

European Meeting on HIV & Hepatitis 2020

Feasibility And Efficacy Assessment Of Hepatitis B Vaccination Among Adult Plwh And Vulnerable Population In Vinnytsia Region, Ukraine

Hepatotoxicity And The Hepatic Panel Analysis Among HIV-Positive Ukrainian Patients Receiving Efaverentz And Dolutegravir-Containing Modes

Natural Course Of Hepatitis C Virus Infection: Which Factors Affect Spontaneous Clearance Of HCV Among The Ukrainian Population?

Effectiveness And Tolerability Of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/Taf) In HIV-1-Infected Adult Patients In German Routine Clinical Practice – 12-Month Results Of The BICSTaR Cohort

Long-Acting Cabotegravir + Rilpivirine For HIV Treatment: Flair Week 96 Results

Dual Therapy Including Dolutegravir Plus Boosted-Darunavir Ensures High Rate Of Virological Control And Rare Resistance Selection At Failure In Heavily Treatment Experienced PLWH

Real-World Effectiveness Of Elbasvir/Grazoprevir In The Treatment Of Patients With Hepatitis C Virus Genotype 1A Infection In Norway

Dual Therapy With Dolutegravir Plus Lamivudine In Virologically Suppressed Patients

HIV A1 Or B Do Not Differentially Impact Cabotegravir In Vitro Potency Or Durability

Molecular Epidemiology Of The HIV-1 Infection In Cyprus (2017-2019): A Polyphyletic Infection With An Increasing Prevalence Of Drug Resistance

HIV Evolution In Patients Initiating Antiretroviral Therapy During Primary Infection

A Changing Of HIV-1 Genetic Diversity In Russia During The Last Two Decades: Increase Of The Recombinants Prevalence

Unexpected Rising In The Circulation Of Complex HBV Variants Enriched Of HBsAg Vaccine-Escape Mutations In HBV Genotype-D: Potential Impact On HBsAg Detection/Quantification And Vaccination Strategies

Residual Phenotypic Susceptibility To Second Generation Nnrti In Multidrug Resistant HIV-1 From The Prestigio Registry

Susceptibility To HIV-1 Integrase Inhibitors In HIV-1 Sub-Subtype A6 Isolates

Two-Drug Regimen (2DR) For Initial HIV Treatment? – Lessons Learned From 20 Years Resina Cohort

Transmitted Drug Resistance To Integrase Based First-Line HIV Antiretroviral Treatment In The MeditRes HIV Collaboration

Dynamics Of HIV-1 Transmission Clusters In North And Central Italy Over The Years 2012-2019

Exploring Molecular Characteristics And Evolutionary Dynamics Of The HIV-1 Epidemic In Montenegro Through Phylogenetic Analyses

Prevalence And Spatiotemporal Dynamics Of The HIV-1 Circulating Recombinant Form 03_AB (CRF03_AB) In The Former Soviet Union

Short- And Long-Term Direct Medical Costs Of Late And Very Late HIV Presentation

Cabotegravir + Rilpivirine Every 2 Months Is Noninferior To Monthly: ATLAS-2M Study

Treatment Outcome Among People Living With Hiv Starting First-Line Rapid Or GRT Guided ART From 2015 To 2018

Evaluation Of HIV-1 Tropism In Multidrug-Resistant cART Failing Patients

Assessment Of Genotypic Patterns Associated With HIV-1 Sensitivity To Ibalizumab

DTG+3TC vs DTG+TDF/FTC (GEMINI1&2): Confirmed Virologic Withdrawals Through Week 96

Role Of Analitical Treatment Interruption On HIV Peripheral Reservoir Diversification

In Vitro Activity Of Islatravir Against HIV-1 Mutants Harboring Multiple NRTI Resistance Mutations

Case Report: Poor Adherence To Dolutegravir Is Associated With Selection Of Resistance Mutations T66I, G118R, E138A And L74I

Multicentric Castleman Disease HHV-8 Related In A HIV Patient

HIV Seronegativity After Rapid Art: A Case Demonstrating Future Challenges In HIV Confirmation Testing In The Era Of iART

Variability In HIV Proviral DNA Genotyping Results From A Single Blood Draw

Virological Efficacy And Resistance Evaluation In People Living With HIV Starting An STR Regimen

Resistant Minority Variants Observed In Failing Patients At Week 48 In Anrs 170 Quatuor Trial (A 4/7 Days Maintenance Strategy Vs A 7/7 Days Regimen In Patients With Controlled Viral Load)

Molecular Characterization In Hcv Late Relapser Patients Treated With Direct-Acting Antiviral (DAA) Drugs

Clinical And Virological Characteristics And Retreatment Of Patients With Chronic Hepatitis C Virus Infection And Failure To Sofosbuvir, Velapatasvir, And Voxilaprevir In Real-World

Pharmaco-Virological Algorithm To Target Risk Of Resistance Among A Population Of HIV-Infected Female Sex Workers In Togo

Impact Of Sexually Transmitted Infections On Seminal HIV Levels Among Undetectable Patients

The Burden Of Serious Non-AIDS-Defining Events Among Admitted cART-Naive HIV/AIDS Patients In China: An Observational Cohort Study

Bone Mineral Density In Patients With HIV Infection And Chronic Hepatitis C

The Prevalence Of Hepatitis B Virus Seromarkers In Patients With HIV/Hcv Coinfection. An Egyptian Cross-Sectional Study

Seroprevalence And Co-Infections HIV, HBV And HCV Among Clinic Attenders At Laquintinie Hospital In Douala, Cameroon

Using Next-Generation Sequencing To Understand The Phylogenetics And Networks Of Generalised HIV Epidemics In Africa

The Efficacy Of First-Line Therapy Based On Rpv In HIV-Infected Patients With Pre-Existing E138A Mutation In Reverse Transcriptase

Number, Type And Cost Of Microbiological Assays During HIV Pre-Exposure Prophylaxis: The Experience Of A French Hospital

Breaking Bad: Chems, Sex And Sexual Health

Determination Of Drug Resistance Of Hepatitis C Virus To NS5A Protein Inhibitors As A New Approach To Personalized Medicine

Using Next-Generation Sequencing To Assess The Differences In HIV Drug Resistance Pre- And Post-Treatment In A Treatment As Prevention Trial

Association Of Viral Reservoir With HIV Infection Duration, Viral Load And CD4 Count

Creation Of An Italian HIV Dna Network For The Validation And Clinical Use Of HIV-1 DNA Quantification Assays

Exploratory Evaluation For The Optimization Of Next Generation Sequencing HIV-1 Drug Resistance Outcomes Based On An In-House RNA Extraction Protocol

Associations Between Vitamin D And Fibrosis, Genotype, Viral Load In Patients Having Chronic Hepatitis C

The Quantification Of HBeAg Levels Differ Among The Different Phases Of Hbv Infection, And Can Predict Therapeutic Outcome In The Setting Of Immunosuppression Driven Hbv Reactivation

The Effectiveness Of The Application Of Serological Tests And Laboratory Indicators As Part Of Rita For The Detection Of Recent HIV Infection

Ibalizumab Shows In Vitro Activity Against Group A And Group B HIV-2 Clinical Isolates

TDF Surveillance And Clinically Relevant Resistance In Spain: 2019 Update

HCV Resistance Associated Variants Following Directly Acting Agent Therapy Failure- Real Life Data From Poland

Prevalence Of Transmitted Resistance Mutations To Rilpivirine And Doravirine In Treatment-Naive Patients In A Large Clinical And Resistance Database

Absence Of GS-6207 Phenotypic Resistance In HIV Gag Cleavage Site Mutants, Patient Isolates With Gag Polymorphisms, And Isolates With Resistance To Existing Drug Classes

Susceptibility To Bnabs Of Transmitted HIV Variants Among Recent Infections In France

Genotyping And Treatment Issues With Unusual 1E And 1G HCV Subtypes From African Subjects: Report Of Two Cases

Substantial Clustered Transmission Of The Acute Hepatitis C Among HIV Co-Infected Men-Who-Have-Sex-With-Men (MSM)

Antiretroviral Resistance In Patients With Multiple Treatment Failure In A Low-Middle Income Setting

Prevalence And Correlates Of Pre-Treatment HIV Drug Resistance Among HIV-Infected In The Republic Of Belarus

Late Presentation And HIV Drug Resistance In Patients Followed In Portugal Between 1984-2017

Prevalence Of Pretreatment HIV-1 Drug Resistance Among Treatment-Naïve Patients In The Russian Federation, 2014–2018

Genetic Characteristic Of HIV-1 In Patients With Treatment Failure In Kyrgyzstan In 2017-2018

The HBV Treatment Outcome To cART In HBV/HIV Co-Infected Patients Who Failed Lamivudine Containing Regimens